文献速递细菌感染、耐药与抗菌药物新发突发、热带与寄生虫病

从英国和丹麦分离的新发人类呼吸道病原体壶形支原体的表型和基因型抗菌药物敏感性模式

Phenotypic and genotypic antimicrobial susceptibility patterns of the emerging human respiratory pathogen Mycoplasma amphoriforme isolated from the UK and Denmark.
PubMed 文献 · J Antimicrob Chemother · 2022-01-01

该研究对来自英国和丹麦患者的7株壶形支原体(Mycoplasma amphoriforme)进行微量肉汤稀释法药敏试验和全基因组测序。4株(57%)对莫西沙星和左氧氟沙星耐药,所有菌株对四环素和来法莫林敏感。耐药菌株携带ParC S89F突变,大环内酯-林可酰胺耐药株H29携带23S rRNA A2059G突变。

要点

  • 7株壶形支原体中4株(57%)对莫西沙星和左氧氟沙星耐药。
  • 所有菌株对四环素和来法莫林敏感。
  • 耐药菌株存在ParC S89F突变;H29株有23S rRNA A2059G突变。

核心结论

  • 据作者所知,这是首次配对壶形支原体的表型和基因型耐药数据,并证实两者之间存在相关性。
  • 这些数据提示,在抗菌药物耐药高流行的背景下,需要对高危患者的分离株进行针对性检测和耐药性测定。

研究设计与样本

  • 研究采用微量肉汤稀释法,按照CLSI支原体指南,检测7株壶形支原体对7种抗菌药物的敏感性。
  • 对每株分离株进行全基因组测序以鉴定耐药相关突变,并基于基因组共识序列设计PCR引物扩增parC基因的QRDR。

主要发现

  • 7株分离株中,4株(57%)对莫西沙星(0.5-1 mg/L)和左氧氟沙星(1-2 mg/L)耐药,敏感株的MIC分别为0.03-0.06 mg/L和0.006 mg/L。
  • 分离株H29对7种受试抗菌药物中的5种耐药:莫西沙星0.5 mg/L、左氧氟沙星2 mg/L、阿奇霉素64 mg/L、红霉素128 mg/L、克林霉素64 mg/L。
  • 所有分离株对四环素(0.06 mg/L)和来法莫林(0.001-0.004 mg/L)敏感。
  • 基因组数据证实,所有氟喹诺酮耐药分离株的ParC蛋白中存在S89F突变,大环内酯-林可酰胺耐药分离株H29的23S rRNA基因中存在A2059G突变。

关键数值与推荐

  • 对莫西沙星耐药的4株(57%)MIC为0.5-1 mg/L,敏感株MIC为0.03-0.06 mg/L。
  • 对左氧氟沙星耐药的4株(57%)MIC为1-2 mg/L,敏感株MIC为0.006 mg/L。
  • 分离株H29对阿奇霉素MIC 64 mg/L、红霉素128 mg/L、克林霉素64 mg/L。
  • 所有分离株对四环素MIC 0.06 mg/L、来法莫林MIC 0.001-0.004 mg/L。
  • 氟喹诺酮耐药分离株均存在ParC S89F突变;H29株存在23S rRNA A2059G突变。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To determine the phenotypic and genotypic antibiotic susceptibility of Mycoplasma amphoriforme isolates recovered from patients in the UK and Denmark. METHODS: Seven isolates of M. amphoriforme were examined for antimicrobial susceptibility to seven antibiotics using the microbroth dilution assay in line with the CLSI guidelines for mycoplasmas. Each isolate was additionally subjected to WGS to identify resistance-associated mutations. Based on the consensus sequences from the genomic data, PCR primers were designed, and tested, for the amplification of the QRDR within the parC gene. RESULTS: Of the seven isolates investigated, four (57%) were resistant to moxifloxacin (0.5-1 mg/L) and levofloxacin (1-2 mg/L), compared with those that were susceptible (0.03-0.06 and 0.006 mg/L, respectively). Isolate H29 was resistant to five of the seven antibiotics tested: moxifloxacin, 0.5 mg/L; levofloxacin, 2 mg/L; azithromycin, 64 mg/L; erythromycin, 128 mg/L; and clindamycin, 64 mg/L. All isolates were susceptible to tetracycline (0.06 mg/L) and lefamulin (0.001-0.004 mg/L). Mutations from genomic data confirmed the presence of an S89F mutation within the ParC protein among all fluoroquinolone-resistant isolates and an A2059G mutation in the 23S rRNA gene in the macrolide- and lincosamide-resistant isolate H29. CONCLUSIONS: To the best of our knowledge, this is the first time where phenotypic and genotypic resistance data have been paired for M. amphoriforme confirming a correlation between the two. These data suggest the need for focused testing and resistance determination of isolates from high-risk patients given the backdrop of a high prevalence of antimicrobial resistance.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Day J, Afshar B, Rowlands RS, et al. Phenotypic and genotypic antimicrobial susceptibility patterns of the emerging human respiratory pathogen Mycoplasma amphoriforme isolated from the UK and Denmark. J Antimicrob Chemother. 2022. PMID: 36048620. doi:10.1093/jac/dkac293

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。